DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,258 filers reported holding DANAHER CORPORATION in Q3 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $4,420,000 | -83.5% | 25,000 | -86.5% | 0.08% | -89.6% |
Q3 2019 | $26,720,000 | -15.0% | 185,000 | -15.9% | 0.74% | +2.2% |
Q2 2019 | $31,442,000 | -25.3% | 220,000 | -31.0% | 0.72% | +32.8% |
Q1 2019 | $42,099,000 | +2640.8% | 318,887 | +2040.2% | 0.54% | +2485.7% |
Q4 2018 | $1,536,000 | -93.4% | 14,900 | -93.0% | 0.02% | -92.7% |
Q3 2018 | $23,223,000 | +1169.0% | 213,722 | +808.7% | 0.29% | +1410.5% |
Q4 2016 | $1,830,000 | – | 23,520 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |